Profile image
By Market Study Report
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Radiopharmaceutical Market Outlook 2022: Top Companies, Trends and Growth Factors Details for Business Development

Tuesday, April 11, 2017 6:18
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request a sample copy of Radiopharmaceutical Market Research Report @

Market Segment by Manufacturers, this report covers

  • Bayer
  • Triad Isotopes
  • Lantheus
  • GE Healthcare
  • Mallinckrodt
  • Eli Lilly
  • Bracco Imaging
  • Navidea
  • Nordion
  • IBA Group
  • Jubilant Pharma

Market Segment by Regions, regional analysis covers

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes

Market Segment by Applications, can be divided into

  • Oncology
  • Cardiology
  • Other

Browse full table of contents and data tables For Radiopharmaceutical Market Research Report @

Table of Contents

11 Global Radiopharmaceutical Market Segment by Application

    11.1 Global Radiopharmaceutical Sales Market Share by Application (2012-2017)

    11.2 Oncology Sales Growth (2012-2017)

    11.3 Cardiology Sales Growth (2012-2017)

    11.4 Other Sales Growth (2012-2017)

12 Radiopharmaceutical Market Forecast (2017-2022)

    12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)

    12.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)

        12.2.1 North America Radiopharmaceutical Market Forecast (2017-2022)

        12.2.2 Europe Radiopharmaceutical Market Forecast (2017-2022)

        12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2017-2022)

        12.2.4 South America Radiopharmaceutical Market Forecast (2017-2022)

        12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2017-2022)

    12.3 Radiopharmaceutical Market Forecast by Type (2017-2022)

    12.4 Radiopharmaceutical Market Forecast by Application (2017-2022)

13 Sales Channel, Distributors, Traders and Dealers

    13.1 Sales Channel

        13.1.1 Direct Marketing

        13.1.2 Indirect Marketing

        13.1.3 Marketing Channel Future Trend

    13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

    15.1 Methodology

    15.2 Analyst Introduction

    15.3 Data Source

Enquire for Discount Radiopharmaceutical Market Research Report @

Related Reports: -

Global Echocardiography (ECG) Devices Market 2017-2021

ECG is a process of recording the electrical signals associated with cardiac activity over a period of time. It has become a routine part of any medical evaluation and has been used as a diagnostic test in the past seven decades. ECG is used for the diagnosis and treatment of various types of heart conditions such as myocardial infarctions (heart attacks) and arrhythmias (abnormal heart rhythms). ECG is a non-invasive procedure used for the diagnosis of heart conditions. The rising incidences of CVDs have led to the rise in the use of ECG devices. The ECG devices market is further segmented into resting ECGs, stress testing, cardiopulmonary stress testing, and Holter monitoring systems.

About Us:, a Skyline Market Research LLP brand, is an online aggregator of market research reports. offers a comprehensive collection of full length reports on global and regional markets in 100+ industry verticals. We have partnered with some of the leading business and market research publishing houses and regularly update our online library to offer wide range of reports to our customers.

Contact Us:

Market size forecasters

The Green Suite #4594,

Dover, DE 19901

United States

Phone: 1-201-355-0868

US Toll Free: 1-866-764-2150

Email: [email protected]


Connect with us: LinkedIn | Twitter

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.